INNOVATION

BIOSYNEX provides each distribution channel (biology laboratories, medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc) with a wide range of adapted products.

BIOSYNEX focuses its development and distribution choices on market-specific, world-class niches through home-made products with high added value (RDTs, women’s health, treatment monitoring, medical assistance, etc).

In order to maintain its position, BIOSYNEX opted for a proactive intellectual property protection policy by filing its own patents, which guarantees its role as an innovative player in the biology sector.

SYNERGY

In order to improve its performance and productivity, BIOSYNEX integrates all the necessary know-how from the conception to the commercialization of its products in France and abroad :

Production
Purchasing
Logistics
Marketing / Communication
Distribution
Quality / Regulatory
Administration / Finance
International

Product compliance is the responsibility of the Quality / Regulatory unit.

BIOSYNEX has obtained the ISO 9001v2015 and ISO 13485v2016 certifications.

The products for which Biosynex is legal manufacturer meet the requirements of:

the Directive 98/79/(EC) and in transition the European regulation (EU)2017/746 for IVDs (InVitro devices)
the European regulation EU2017/745 for MDs (Medical Devices).

Compliance with CE marking requirements is verified according to the regulations in force for all products.

Biosynex - Model COVID-19 Ag+ BSS - SARS-CoV-2 Antigen Detection Test